| 000 | 01852 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516084803.0 | ||
| 264 | 0 | _c20120619 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.23159 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGolombick, Terry | |
| 245 | 0 | 0 |
_aMonoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cMay 2012 |
||
| 300 |
_a455-60 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmino Acids _xurine |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Light Chains _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonoclonal Gammopathy of Undetermined Significance _xblood |
| 650 | 0 | 4 |
_aMultiple Myeloma _xprevention & control |
| 650 | 0 | 4 |
_aMyeloma Proteins _xanalysis |
| 650 | 0 | 4 |
_aParathyroid Hormone _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVitamin D _xblood |
| 700 | 1 | _aDiamond, Terrence H | |
| 700 | 1 | _aManoharan, Arumugam | |
| 700 | 1 | _aRamakrishna, Rajeev | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 87 _gno. 5 _gp. 455-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.23159 _zAvailable from publisher's website |
| 999 |
_c21676105 _d21676105 |
||